Biotinidase deficiency is an inherited condition where the body cannot properly recycle biotin, a vitamin essential for breaking down food into energy. When caught early through newborn screening and treated with simple daily biotin supplements, children with this condition can develop completely normally, avoiding serious complications that could otherwise affect their brain, vision, hearing, and overall growth.

Understanding Biotinidase Deficiency

Biotinidase deficiency is a genetic disorder that affects how the body handles a vitamin called biotin, also known as vitamin B7 or vitamin H. This vitamin plays a crucial role in helping the body convert proteins, fats, and carbohydrates from food into energy that cells can use. Normally, the body recycles biotin through an enzyme called biotinidase, but in people with this condition, this enzyme either doesn’t work properly or is missing altogether.^[1]

The condition comes in two forms. Profound biotinidase deficiency is the more severe type, where the enzyme activity drops below 10 percent of normal levels. This form can cause serious health problems if not treated. Partial biotinidase deficiency is milder, with enzyme activity between 10 and 30 percent of normal. People with the partial form may experience symptoms only during times of stress, such as when they have an infection or illness.^[2]

Without enough working biotinidase enzyme, the body cannot recycle biotin effectively. This creates a shortage of free biotin, which several important enzymes need to function. These biotin-dependent carboxylases include four key enzymes that help process amino acids, break down certain fats, and help the body produce glucose for energy. When these enzymes can’t work properly, toxic waste products can build up in the body, leading to the various symptoms associated with the condition.^[5]

Epidemiology

Biotinidase deficiency affects approximately 1 in 60,000 newborns worldwide, making it a rare genetic condition. This number includes both the profound and partial forms of the disorder combined.^[1] In the United States specifically, it is estimated that fewer than 70 babies are born with some form of this condition each year, highlighting just how uncommon it is.^[8]

The condition affects people across all ethnic backgrounds and geographic regions. There doesn’t appear to be a significant difference in how often it occurs between males and females. Because biotinidase deficiency is inherited in a specific genetic pattern, it can occur in any family, though it is more likely to appear in families where parents are blood relatives or come from populations with higher carrier rates.^[1]

The recognition of biotinidase deficiency as a public health concern has grown significantly since newborn screening programs began testing for it. Many regions now include this condition in their routine newborn screening panels, which has helped identify cases earlier and improved outcomes for affected children. This early detection through screening has also helped researchers better understand how common the condition truly is.^[8]

Causes

Biotinidase deficiency is caused by mutations in the BTD gene, which provides instructions for making the biotinidase enzyme. This gene is located on human chromosomes and contains the blueprint the body needs to produce properly functioning biotinidase. When mutations occur in this gene, they can reduce or completely eliminate the enzyme’s activity.^[1]

The condition follows an autosomal recessive inheritance pattern. This means that a child must inherit two copies of the mutated BTD gene—one from each parent—to develop the condition. Parents who each carry one mutated copy are called carriers, and they typically don’t show any signs of the condition themselves because they still have one working copy of the gene that produces enough enzyme for normal function.^[1]

When both parents are carriers, there is a 25 percent chance with each pregnancy that their child will inherit both mutated genes and have biotinidase deficiency. There is a 50 percent chance the child will be a carrier like the parents, and a 25 percent chance the child will inherit two normal copies of the gene. Genetic counseling can help families understand these risks and make informed decisions about family planning and testing.^[1]

Risk Factors

The primary risk factor for biotinidase deficiency is having parents who both carry a mutated copy of the BTD gene. Since carriers typically have no symptoms, many parents don’t know they carry the mutation until they have a child diagnosed with the condition or undergo carrier screening. Families with a known history of biotinidase deficiency in previous generations are at higher risk, as the carrier status may run in the family.^[1]

Children born to parents who are blood relatives, such as cousins, have a higher risk of inheriting two copies of the same mutated gene because the parents are more likely to share similar genetic makeup. This is why consanguinity increases the risk of many autosomal recessive conditions, including biotinidase deficiency.^[1]

Certain ethnic or geographic populations may have slightly higher carrier rates for specific BTD gene mutations, though the condition can occur in any population. Once a child is born with biotinidase deficiency, siblings have a 25 percent chance of also having the condition with each pregnancy, since both parents are confirmed carriers. Genetic testing can determine whether siblings are affected, carriers, or have two normal copies of the gene.^[1]

Symptoms

In children with profound biotinidase deficiency who are not treated, symptoms typically begin to appear between one week and ten years of age, though most commonly emerge within the first few months of life. The range and severity of symptoms can vary considerably between individuals, but early signs often involve the nervous system and skin.^[2]

Seizures are among the most common and concerning symptoms. These can range from mild episodes to severe convulsions that are difficult to control with standard anti-seizure medications. The seizures occur because the buildup of toxic substances in the body affects normal brain function. Many infants also develop hypotonia, which means they have weak muscle tone and appear floppy or have difficulty holding their head up or sitting.^[2]

Skin and hair problems are characteristic features of biotinidase deficiency. Affected children often develop a distinctive red, scaly skin rash that may come and go or persist over time. Alopecia, or hair loss, is also common, and children may lose hair on their scalp, eyebrows, and eyelashes. These skin and hair changes occur because the enzymes that need biotin to function properly are involved in maintaining healthy skin and hair follicles.^[1]

Vision and hearing problems can develop if the condition goes untreated. Optic atrophy, which is damage to the optic nerve, can lead to vision loss. Hearing loss may occur gradually and can range from mild to profound. These sensory problems happen because the nerves that transmit signals for vision and hearing are particularly vulnerable to the metabolic disturbances caused by biotin deficiency.^[2]

Problems with movement and balance, known as ataxia, frequently affect untreated children. They may have difficulty walking, experience unsteady movements, or have poor coordination. Developmental delays are also common, with children reaching milestones like sitting, walking, and talking later than expected. These developmental issues result from the effects of the metabolic imbalance on the developing brain and nervous system.^[2]

Respiratory problems, including difficulty breathing or episodes of rapid breathing, can occur in some children. Affected individuals may also develop recurrent fungal infections called candidiasis, often appearing as white patches in the mouth (thrush) or diaper rashes that don’t respond to typical treatments. These immune-related symptoms suggest that biotin deficiency also affects the body’s ability to fight certain infections.^[1]

Children with partial biotinidase deficiency may experience milder versions of these symptoms, or they may remain symptom-free unless they face physical stress from illness or infection. During these stressful periods, they might develop temporary hypotonia, skin rashes, or hair loss that improve once the stress passes.^[2]

In adolescents and adults who have gone undiagnosed, the condition may present differently. These individuals often develop problems with the spinal cord called myelopathy and optic nerve damage. Because their symptoms can resemble multiple sclerosis, they are sometimes initially misdiagnosed. Most experience significant improvement once they begin biotin supplementation, even after years of symptoms.^[2]

Prevention

Since biotinidase deficiency is an inherited genetic condition, it cannot be prevented in the traditional sense. However, early detection and treatment can prevent all symptoms from developing, which is why newborn screening programs are so valuable. In many regions, testing for biotinidase deficiency is now part of routine newborn screening, using a small blood sample collected from the baby’s heel shortly after birth.^[8]

Families with a known history of biotinidase deficiency can pursue genetic counseling before or during pregnancy. Genetic counselors can assess the risk of having a child with the condition and discuss options for carrier testing. If both parents are confirmed carriers, they can make informed decisions about family planning and prepare for potential management needs if they choose to have children.^[1]

Prenatal testing is available for families at high risk, typically when both parents are known carriers or when a previous child has been diagnosed with biotinidase deficiency. This testing can be performed through procedures like amniocentesis or chorionic villus sampling, which analyze fetal cells to determine whether the baby has inherited two mutated copies of the BTD gene.^[8]

For individuals already diagnosed with biotinidase deficiency, prevention focuses on avoiding complications through consistent treatment. Taking prescribed biotin supplements daily as directed prevents the development of all symptoms associated with the condition. Missing doses or stopping treatment can lead to symptom development, so maintaining a reliable supplement routine is essential.^[7]

Certain situations can increase biotin needs or affect biotin status, even in people without biotinidase deficiency. For individuals with the condition, being aware of these factors is important. Illness, infection, or other physical stresses may temporarily increase biotin requirements, though regular supplementation usually provides an adequate buffer. Some medications may affect biotin levels or enzyme function, so discussing all medications with healthcare providers is advisable.^[2]

Pathophysiology

Understanding what happens in the body when biotinidase doesn’t work properly helps explain why the symptoms occur. Biotin is a water-soluble B vitamin that functions as an essential coenzyme for four specific carboxylase enzymes in the body. These enzymes are pyruvate carboxylase, propionyl-CoA carboxylase, beta-methylcrotonyl-CoA carboxylase, and acetyl-CoA carboxylase. Each of these enzymes plays a vital role in different metabolic pathways.^[5]

Under normal circumstances, biotin attaches to these carboxylase enzymes to help them function. Once these enzymes complete their work, biotinidase’s job is to cut the biotin free so it can be recycled and used again. This recycling system is remarkably efficient—the body can reuse the same biotin molecules many times. Dietary biotin from foods like eggs, liver, and milk supplements this recycled biotin, but the recycling process is the body’s primary source of available biotin.^[1]

When biotinidase activity is severely reduced or absent, biotin remains bound to proteins and cannot be freed for reuse. The body’s pool of available free biotin gradually becomes depleted. As free biotin levels fall, the four carboxylase enzymes that depend on biotin cannot function properly. This creates what is called multiple carboxylase deficiency because several carboxylase enzymes are affected simultaneously.^[1]

The impaired function of these carboxylases has cascading effects throughout metabolism. Pyruvate carboxylase is crucial for making glucose through a process called gluconeogenesis. When this enzyme doesn’t work well, the body struggles to maintain normal blood sugar levels, particularly during fasting or illness. Propionyl-CoA carboxylase and beta-methylcrotonyl-CoA carboxylase are involved in breaking down certain amino acids and odd-chain fatty acids. When these enzymes are impaired, toxic breakdown products can accumulate.^[5]

These accumulated toxic substances include organic acids that make the blood too acidic, a condition called metabolic acidosis. The brain and nervous system are particularly sensitive to both the acidosis and the accumulation of toxic metabolites. This explains why neurological symptoms like seizures, developmental delays, and problems with movement are so prominent in untreated biotinidase deficiency.^[5]

The skin and hair changes occur because biotin-dependent enzymes are also involved in the synthesis of fatty acids needed for healthy skin and hair growth. The hearing and vision problems result from damage to specialized nerve cells in the ears and eyes that are particularly vulnerable to the metabolic disturbances. The immune system changes that lead to increased susceptibility to fungal infections may relate to biotin’s role in supporting normal immune function, though the exact mechanisms are still being studied.^[1]

What makes biotinidase deficiency particularly treatable is that supplementing with free biotin bypasses the recycling problem entirely. When large amounts of free biotin are provided through oral supplements, enough biotin becomes available to keep the carboxylase enzymes working, even though the recycling system isn’t functioning. This is why biotin supplementation is so effective at preventing and treating symptoms. The biotin dosage needed is much higher than normal dietary amounts, but because biotin is water-soluble, excess amounts are safely excreted in urine rather than building up to toxic levels.^[7]

In people with profound biotinidase deficiency, enzyme activity is less than 10 percent of normal, meaning the recycling system is severely impaired. In partial deficiency, where enzyme activity is between 10 and 30 percent of normal, the recycling system works somewhat, which is why these individuals may only develop symptoms during times of increased metabolic stress when biotin demands temporarily exceed what the limited recycling can provide.^[1]